NCT03607903View on ClinicalTrials.gov

Adalimumab Microneedles in Healthy Volunteers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 11, 2018

Primary Completion Date

October 30, 2018

Study Completion Date

October 30, 2018

Conditions
PainInjection Site
Interventions
BIOLOGICAL

Adalimumab ID

Adalimumab intradermal using MicronJet600 microneedle from NanoPass

BIOLOGICAL

Adalimumab SC

Adalimumab subcutaneous using regular needle

OTHER

Saline ID

Saline intradermal using MicronJet600 microneedle from NanoPass

OTHER

Saline SC

Saline subcutaneous using regular needle

Trial Locations (1)

2333 CL

Centre for Human Drug Research, Leiden

All Listed Sponsors
collaborator

Leiden University Medical Center

OTHER

collaborator

Leiden Academic Center for Drug Research, the Netherlands

UNKNOWN

lead

Centre for Human Drug Research, Netherlands

OTHER

NCT03607903 - Adalimumab Microneedles in Healthy Volunteers | Biotech Hunter | Biotech Hunter